Nyeste anskaffelser av vaksiner mot meslinger, kusma og røde hunder i Norge
2020-07-22MMR Vaccine for the Childhood Immunisation Programme (Folkehelseinstituttet)
Folkehelseinstituttet [the Norwegian Institute of Public Health] is carrying out an open tender competition with the aim of entering into a framework agreement for the delivery of MMR vaccines. I.e. a combination vaccine against measles, mumps and rubella (living) for the Norwegian Childhood Immunisation Programme.
The competition is carried out as an open tender competition in accordance with the Public Procurement Regulations' Parts 1 and 3. The competition is implemented electronically in the CTM …
Vis anskaffelsen » Nevnte leverandører:MSD (Norge) AS
2016-11-29MMR-vaccination — Combination vaccination against measles, mumps and german/measlesrubella (Folkehelseinstituttet)
The procurement shall cover the need for a combination vaccination against measles, mumps and german measles/rubella under the Norwegian child vaccination programme. The vaccination regime consists of 2 doses, given at 15 months old and in the 6th year at school.
Based on current calculations, including stand-by, the annual need for vaccinations will be approx. 150 000 doses.
Vis anskaffelsen »
2012-04-19Combination vaccine for the Norwegian childhood immunisation programme, measles, mumps, rubella (Nasjonalt folkehelseinstitutt)
The Norwegian Institute of Public Health, henceforth referred to as the Awarding Authority, shall carry out an open tender contest for procurement of combination vaccines for the Norwegian childhood immunisation programme. The combination vaccine procured is for protection against measles, mumps and rubella.
The procurement includes delivery of combination vaccine against measles, mumps and rubella (ATC code: J07B D52). The extent is between 120 000 doses to 180 000 doses per annum for use in the …
Vis anskaffelsen »